Study shows nicotine replacements support, aid smoking cessation
05 Jul 2025 06:00pm
Photo for illustrative purposes only - Pixabay
OFFERING various nicotine replacements or vapes with behavioural support helps people leaving rehab stay smoke-free, Xinhua reported, citing findings from a new clinical study.
The study, which tracked over 360 adults exiting detox programmes, added to growing evidence that, with consistent support and a variety of nicotine replacement options, people in recovery can achieve meaningful progress in quitting smoking, according to a release on Tuesday from Flinders University in South Australia, which led the study. Photo for illustrative purposes only - Pixabay
This potentially saves lives and reduces the heavy health burden associated with tobacco use in this vulnerable population, according to the study published in the July issue of the Lancet Public Health journal.
"People recovering from substance use are more than twice as likely to smoke as the general population, and far more likely to suffer and die from tobacco-related illness," said the study's lead author, Billie Bonevski, director of the Flinders Health and Medical Research Institute.
Participants were randomly assigned either a 12-week supply of vapes or a combination of nicotine replacement therapy products such as patches, gum, lozenges, inhalators, and mouth sprays.
Both groups also received behavioural counselling through Quitline services, the researchers said.
After nine months, 10 per cent of participants in both groups remained smoke-free, a notable achievement in a population with high smoking rates and long-term quitting is rare, the study showed.
"This isn't about one therapy outperforming another -- it's about building a system that gives people the best chance to succeed," Bonevski said.
Bonevski added that ongoing support and access to multiple quit tools matter more than the type of nicotine therapy, and called for smoking cessation to be fully integrated into addiction treatment. - BERNAMA-XINHUA
More Like This
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sinar Daily
7 hours ago
- Sinar Daily
Study shows nicotine replacements support, aid smoking cessation
This potentially saves lives and reduces the heavy health burden associated with tobacco use in this vulnerable population 05 Jul 2025 06:00pm Photo for illustrative purposes only - Pixabay OFFERING various nicotine replacements or vapes with behavioural support helps people leaving rehab stay smoke-free, Xinhua reported, citing findings from a new clinical study. The study, which tracked over 360 adults exiting detox programmes, added to growing evidence that, with consistent support and a variety of nicotine replacement options, people in recovery can achieve meaningful progress in quitting smoking, according to a release on Tuesday from Flinders University in South Australia, which led the study. Photo for illustrative purposes only - Pixabay This potentially saves lives and reduces the heavy health burden associated with tobacco use in this vulnerable population, according to the study published in the July issue of the Lancet Public Health journal. "People recovering from substance use are more than twice as likely to smoke as the general population, and far more likely to suffer and die from tobacco-related illness," said the study's lead author, Billie Bonevski, director of the Flinders Health and Medical Research Institute. Participants were randomly assigned either a 12-week supply of vapes or a combination of nicotine replacement therapy products such as patches, gum, lozenges, inhalators, and mouth sprays. Both groups also received behavioural counselling through Quitline services, the researchers said. After nine months, 10 per cent of participants in both groups remained smoke-free, a notable achievement in a population with high smoking rates and long-term quitting is rare, the study showed. "This isn't about one therapy outperforming another -- it's about building a system that gives people the best chance to succeed," Bonevski said. Bonevski added that ongoing support and access to multiple quit tools matter more than the type of nicotine therapy, and called for smoking cessation to be fully integrated into addiction treatment. - BERNAMA-XINHUA More Like This
The Star
19 hours ago
- The Star
Norway, Ukraine sign health partnership deal to strengthen medical cooperation
OSLO, July 4 (Xinhua) -- Norway and Ukraine have signed a comprehensive health partnership agreement aimed at deepening cooperation and improving healthcare services, the Norwegian government announced in a press release on Friday. The agreement was signed earlier this week in Kyiv by Norway's Minister of Health and Care Services Jan Christian Vestre and Ukraine's Minister of Health Viktor Liashko during Vestre's multi-day visit to Ukraine. The new partnership seeks to facilitate direct exchanges between health authorities, educational institutions, and medical professionals from both countries. Vestre emphasized the mutual benefits of the cooperation. "We can learn a lot from Ukraine in areas such as how to organize a health service in war, civil-military cooperation and the use of technology. From Norway's side, we can assist Ukraine in areas such as mental health, rehabilitation and antimicrobial resistance," he noted. Norway's support to Ukraine's health sector is part of the broader Nansen Program, which channels both civilian and military assistance. Vestre said his visit provided valuable insight into how Norway's contributions are benefiting Ukraine's health services. Norway's aid to Ukraine's health sector is mainly delivered through major international organizations such as the World Bank, the World Health Organization, and the Council of Europe Development Bank. Norway also provides humanitarian support to Ukraine, including medical evacuations and treatment for Ukrainian patients in Norwegian hospitals.
The Star
a day ago
- The Star
U.S. researchers develop AI model improving sudden cardiac death prediction
LOS ANGELES, July 4 (Xinhua) -- Researchers at Johns Hopkins University have developed a new artificial intelligence (AI) model that significantly outperforms current clinical guidelines in identifying patients at high risk of sudden cardiac death, according to a newly published study. The AI system, known as Multimodal AI for ventricular Arrhythmia Risk Stratification (MAARS), integrates cardiac MRI images with a wide range of patient health records to detect hidden warning signs, offering a new level of precision in cardiovascular risk prediction. The study, published this week in Nature Cardiovascular Research, focused on hypertrophic cardiomyopathy, one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young people. "Currently we have patients dying in the prime of their life because they aren't protected and others who are putting up with defibrillators for the rest of their lives with no benefit," said senior author Natalia Trayanova, a researcher focused on using AI in cardiology. "We have the ability to predict with very high accuracy whether a patient is at very high risk for sudden cardiac death or not." Clinical guidelines used in the United States and Europe currently have an estimated accuracy of only 50 percent in identifying at-risk patients. In contrast, the MAARS model demonstrated an overall accuracy of 89 percent, and 93 percent for patients aged 40 to 60 -- the group at the greatest risk. The AI model analyzes contrast-enhanced MRI scans for patterns of heart scarring -- something that physicians have traditionally found difficult to interpret. By applying deep learning to this previously underused data, the model identifies key predictors of sudden cardiac death. "Our study demonstrates that the AI model significantly enhances our ability to predict those at highest risk compared to our current algorithms and thus has the power to transform clinical care," said co-author Jonathan Chrispin, a Johns Hopkins cardiologist. The team plans to further test the new model on more patients and expand the new algorithm to use with other types of heart diseases, including cardiac sarcoidosis and arrhythmogenic right ventricular cardiomyopathy.
